scholarly journals Microspheres Encapsulating Immunotherapy Agents Target the Tumor-Draining Lymph Node in Pancreatic Ductal Adenocarcinoma

2020 ◽  
Vol 49 (7) ◽  
pp. 808-823 ◽  
Author(s):  
Booyeon J. Han ◽  
Joseph D. Murphy ◽  
Shuyang Qin ◽  
Jian Ye ◽  
Taylor P. Uccello ◽  
...  
2005 ◽  
Vol 65 (24) ◽  
pp. 11639-11648 ◽  
Author(s):  
Virginie Carrière ◽  
Renaud Colisson ◽  
Carine Jiguet-Jiglaire ◽  
Elisabeth Bellard ◽  
Gérard Bouche ◽  
...  

Author(s):  
Susan N. Thomas

Immunotherapy-based approaches for cancer treatment are of increasing clinical interest. Principles of drug delivery and the emerging field of material design for immunomodulation might hold significant promise for novel approaches in cancer immunotherapy since biomaterials engineering strategies enable enhanced delivery of immune modulatory agents to tissues and cells of the immune system1. One tissue of significant clinical interest in a cancer setting is the tumor-draining lymph node (TDLN), which participates in cancer progression by enabling both metastatic dissemination as well as tumor-induced immune escape. Hence, the TDLN represents a novel target for drug delivery schemes for cancer immunotherapy. We hypothesize that targeted delivery of adjuvants (Adjs) to the TDLN using a biomaterials-based approach might promote antitumor immunity and hinder tumor growth.


2009 ◽  
Vol 16 (11) ◽  
pp. 3070-3079 ◽  
Author(s):  
Gregory Sergeant ◽  
Nadine Ectors ◽  
Steffen Fieuws ◽  
Raymond Aerts ◽  
Baki Topal

1994 ◽  
Vol 16 (1) ◽  
pp. 1-12
Author(s):  
James M. Hammel ◽  
Melissa K. Tuck ◽  
Jon M. Hain ◽  
Alfred E. Chang ◽  
Vernon K. Sondak

1991 ◽  
Vol 134 (2) ◽  
pp. 473-479 ◽  
Author(s):  
Hirohisa Yoshizawa ◽  
Keisuke Sakai ◽  
Alfred E. Chang ◽  
Suyu Shu

2019 ◽  
Author(s):  
Zachary S. Buchwald ◽  
Tahseen H. Nasti ◽  
Christiane S. Eberhardt ◽  
Andreas Wieland ◽  
David Lawson ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document